Related Experiment Video
Updated: Jun 23, 2026

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis
Sharad S Singhal1, Sushma Yadav, Rit Vatsyayan
1Department of Molecular Biology and Immunology, 3500 Camp Bowie Blvd., University of North Texas Health Science Center, Fort Worth, TX 76107-2699, United States. ssinghal@hsc.unt.edu
Abstract:
RLIP76 is a stress-responsive glutathione-electrophile-conjugates (GS-E) and drugs transporter which is over-expressed in different types of cancers. Cdc2 is a cell-cycle check point control kinase which has been shown to bind to RLIP76 during mitosis, such that endocytosis is inhibited. In present studies, we have purified cdc2 and examined its effect on the transport activity of RLIP76 reconstituted into artificial liposomes. Both doxorubicin (DOX) and dinitro-phenyl S-glutathione (DNP-SG) transport were inhibited by cdc2 in a concentration dependent manner. Liposomal delivery of cdc2 to H358 cells caused apoptosis, resulted in an increased intracellular doxorubicin-accumulation and decreased rate of efflux from the cells. In the present communication, we propose that the accumulation-deficient drug-resistance mediated by RLIP76 can be modulated by inhibition of RLIP76 transport activity by cdc2.
Insights
The study shows that Cdc2 kinase inhibits the RLIP76 transporter, which is overexpressed in cancers. This inhibition increases doxorubicin accumulation in cancer cells, offering a potential strategy to overcome drug resistance.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- RLIP76 is a transporter for glutathione-electrophile-conjugates (GS-E) and drugs, overexpressed in various cancers.
- Cdc2 kinase interacts with RLIP76 during mitosis, inhibiting endocytosis.
Purpose of the Study:
- To investigate the effect of purified Cdc2 on RLIP76 transport activity.
- To explore the potential of modulating RLIP76-mediated drug resistance using Cdc2.
Main Methods:
- Purification of Cdc2 kinase.
- Reconstitution of RLIP76 into artificial liposomes.
- Assay of doxorubicin (DOX) and dinitro-phenyl S-glutathione (DNP-SG) transport.
- Liposomal delivery of Cdc2 to H358 cells.
Main Results:
- Cdc2 inhibited both DOX and DNP-SG transport by RLIP76 in a concentration-dependent manner.
- Liposomal Cdc2 induced apoptosis in H358 cells.
- Cdc2 treatment increased intracellular doxorubicin accumulation and decreased its efflux.
Conclusions:
- Cdc2 can inhibit the transport activity of RLIP76.
- Inhibition of RLIP76 by Cdc2 may represent a novel strategy to overcome accumulation-deficient drug resistance in cancer.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Anaphase Promoting Complex
Negative Regulator Molecules
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...

